• Beta Cell Preservation

    Beta Cell Preservation: A Viable Approach

    Type 2 diabetes mellitus (T2DM) is a complex disease marked by the progressive failure of pancreatic β-cell function leading to insulin deficiency and hyperglycemia. Therefore,...

  • Glycemic Durability in YOD

    Young-Onset Diabetes: Verified !

    Although T2DM is considered as a disease related to aging, the prevalence of adult YOD has increased globally. In Asian countries, the surge in YOD prevalence is mainly driven by a sedentary...

  • Galvus

    PI for Galvus PI for Galvus Met PI for Galvus OD Galvus is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus (T2DM). Galvus Met is indicated as an adjunct to diet and exercise to improve...

  • Hazards of Hypoglycemia

    Hazards of Hypoglycemia

    Patient safety has paramount importance in the management type 2 diabetes mellitus (T2DM), and treatment-related hypoglycemia is under increasing scrutiny in this respect. 1 Therefore, the...

  • Mechanism of action

    DPP-4 inhibitors: Deciphering the MoA

    Dipeptidyl peptidase (DPP)-4 is a multifunctional type 2 transmembrane glycoprotein and is involved in immune regulation, signal transduction. DPP-4 inhibitors are a glucose lowering...

  • Comparative effectiveness

    VILDAGLIPTIN – A Better DPP-4 Inhibitor

    The type 2 diabetes mellitus (T2DM) management has become increasingly difficult due to the progressive nature of the disease and associated comorbidities. Moreover, the limitations to...

  • Early Treatment Intensification

    Early Treatment Intensification in T2DM

    Achieving glycemic goals in type 2 diabetes mellitus (T2DM) is directly associated with a reduction in the risk of developing complications. However, in several patients, these goals...

page 

Pages

 of  4
×

Ask Speakers

×

Medical Information Request